Beckman coulter life sciences achieves industry-first with commercial release of anti-TRBC2 conjugated antibody for flow cytometry
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues to lead the way with first-to-market concepts to help laboratories achieve goals faster and with greater accuracy.
Maria Osipova Pietro Lopriore Beckman Coulter Life Sciences Custom Design Services Research Use Only From Beckman Coulter Life Sciencesjan
Source: news-medical.net